Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels

Detalhes bibliográficos
Autor(a) principal: Miyadahira, Mariana Yumi
Data de Publicação: 2018
Outros Autores: Brizot, Maria de Lourdes, Carvalho, Mário Henrique Burlacchini de, Biancolin, Sckarlet Ernandes, Machado, Rita de Cássia Alam, Krebs, Vera Lúcia Jornada, Francisco, Rossana Pulcineli Vieira, Peralta, Cleisson Fábio Andrioli
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/146261
Resumo: OBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that received expectant management (type II, n=6; type III, n=22) or LAPV (type II, n=30; type III, n=9). The main outcomes were gestational age at delivery and survival rate. RESULTS: The smaller fetus presented an absent/reversed “a” wave in the ductus venosus (arAWDV) in all LAPV cases, while none of the expectant management cases presented arAWDV. The median gestational age at delivery was within the 32nd week for expectant management (type II and III) and for type II LAPV, and the 30th week for type III LAPV. The rate of at least one twin alive at hospital discharge was 83.3% and 90.9% for expectant management type II and III, respectively, and 90% and 77.8% for LAPV type II and III, respectively. CONCLUSION: LAPV in type II and III sFGR twins with arAWDV in the smaller fetus seems to yield outcomes similar to those of less severe cases that received expectant management.
id USP-19_4a6cea43efb097090b6624cf8cb5a7ed
oai_identifier_str oai:revistas.usp.br:article/146261
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental VesselsTwin PregnancyMonochorionic PregnancySelective Fetal Growth RestrictionExpectant ManagementLaser Ablation of Placental VesselsPerinatal OutcomesOBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that received expectant management (type II, n=6; type III, n=22) or LAPV (type II, n=30; type III, n=9). The main outcomes were gestational age at delivery and survival rate. RESULTS: The smaller fetus presented an absent/reversed “a” wave in the ductus venosus (arAWDV) in all LAPV cases, while none of the expectant management cases presented arAWDV. The median gestational age at delivery was within the 32nd week for expectant management (type II and III) and for type II LAPV, and the 30th week for type III LAPV. The rate of at least one twin alive at hospital discharge was 83.3% and 90.9% for expectant management type II and III, respectively, and 90% and 77.8% for LAPV type II and III, respectively. CONCLUSION: LAPV in type II and III sFGR twins with arAWDV in the smaller fetus seems to yield outcomes similar to those of less severe cases that received expectant management.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2018-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/14626110.6061/clinics/2018/e210Clinics; Vol. 73 (2018); e210Clinics; v. 73 (2018); e210Clinics; Vol. 73 (2018); e2101980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/146261/139950Copyright (c) 2018 Clinicsinfo:eu-repo/semantics/openAccessMiyadahira, Mariana YumiBrizot, Maria de LourdesCarvalho, Mário Henrique Burlacchini deBiancolin, Sckarlet ErnandesMachado, Rita de Cássia AlamKrebs, Vera Lúcia JornadaFrancisco, Rossana Pulcineli VieiraPeralta, Cleisson Fábio Andrioli2019-05-14T11:48:50Zoai:revistas.usp.br:article/146261Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-14T11:48:50Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
spellingShingle Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
Miyadahira, Mariana Yumi
Twin Pregnancy
Monochorionic Pregnancy
Selective Fetal Growth Restriction
Expectant Management
Laser Ablation of Placental Vessels
Perinatal Outcomes
title_short Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_full Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_fullStr Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_full_unstemmed Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
title_sort Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
author Miyadahira, Mariana Yumi
author_facet Miyadahira, Mariana Yumi
Brizot, Maria de Lourdes
Carvalho, Mário Henrique Burlacchini de
Biancolin, Sckarlet Ernandes
Machado, Rita de Cássia Alam
Krebs, Vera Lúcia Jornada
Francisco, Rossana Pulcineli Vieira
Peralta, Cleisson Fábio Andrioli
author_role author
author2 Brizot, Maria de Lourdes
Carvalho, Mário Henrique Burlacchini de
Biancolin, Sckarlet Ernandes
Machado, Rita de Cássia Alam
Krebs, Vera Lúcia Jornada
Francisco, Rossana Pulcineli Vieira
Peralta, Cleisson Fábio Andrioli
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Miyadahira, Mariana Yumi
Brizot, Maria de Lourdes
Carvalho, Mário Henrique Burlacchini de
Biancolin, Sckarlet Ernandes
Machado, Rita de Cássia Alam
Krebs, Vera Lúcia Jornada
Francisco, Rossana Pulcineli Vieira
Peralta, Cleisson Fábio Andrioli
dc.subject.por.fl_str_mv Twin Pregnancy
Monochorionic Pregnancy
Selective Fetal Growth Restriction
Expectant Management
Laser Ablation of Placental Vessels
Perinatal Outcomes
topic Twin Pregnancy
Monochorionic Pregnancy
Selective Fetal Growth Restriction
Expectant Management
Laser Ablation of Placental Vessels
Perinatal Outcomes
description OBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that received expectant management (type II, n=6; type III, n=22) or LAPV (type II, n=30; type III, n=9). The main outcomes were gestational age at delivery and survival rate. RESULTS: The smaller fetus presented an absent/reversed “a” wave in the ductus venosus (arAWDV) in all LAPV cases, while none of the expectant management cases presented arAWDV. The median gestational age at delivery was within the 32nd week for expectant management (type II and III) and for type II LAPV, and the 30th week for type III LAPV. The rate of at least one twin alive at hospital discharge was 83.3% and 90.9% for expectant management type II and III, respectively, and 90% and 77.8% for LAPV type II and III, respectively. CONCLUSION: LAPV in type II and III sFGR twins with arAWDV in the smaller fetus seems to yield outcomes similar to those of less severe cases that received expectant management.
publishDate 2018
dc.date.none.fl_str_mv 2018-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/146261
10.6061/clinics/2018/e210
url https://www.revistas.usp.br/clinics/article/view/146261
identifier_str_mv 10.6061/clinics/2018/e210
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/146261/139950
dc.rights.driver.fl_str_mv Copyright (c) 2018 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 73 (2018); e210
Clinics; v. 73 (2018); e210
Clinics; Vol. 73 (2018); e210
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222763676336128